Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jun 15, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
John Lynn Jefferies1, Jeffrey A Towbin
1Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
扩张性心肌病包括心室膨胀和功能受损,导致心力衰竭和突然死亡风险. 遗传因素和毒素有所贡献,需要改进治疗策略以获得更好的患者结果.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: